CoV2-OGEN1

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCoV2-OGEN1
Drug Alias Nameprotein subunit vaccine (oral, COVID-19)
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyneos Health
China Registration ClassN/A

Develop Information

Active CompaniesSyneos Health
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A